PEG-IFN Plus Ribavirin Combination Therapy for Older Patients
NCT00956982
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
1251
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C Virus
Interventions
DRUG:
Pegylated interferon alpha-2b plus ribavirin
Sponsor
Kyushu University